Board
Mats Johnson
Chairman of the board
Mats has almost 40 years of experience from the life science area in biotech supply, drug discovery and genetic modifications of plants mainly in different business positions but also from R&D with the companies Pharmacia Biotech, Amersham Biosciences, SweTree Technologies and Bio-Works Technologies.
In the last two companies Mats was CEO, all-in-all, for almost 15 years. SweTree was brought to profitability and Bio-Works was built to an IPO, with relevant industrial structures and global market access.
Mats has during the last 15 years been instrumental in finding financing of almost 500 MSEK for SweTree, its spin-outs and Bio-Works.
Erik Walldén
Director
Mr. Erik Walldén has a record of achievement from over 30 years leadership in the international Life Science industry. He has led the global launching of several new technologies, established and restructured companies, successfully closed private placements and IPOs. He is currently acting as private investor, consultant and advisor through his own company Erik Wallden AB.
Mr. Wallden has been the CEO for the Swedish company Gyros AB (2009-2013. Before that the CEO of the Swedish biotech company Affibody Holding AB (2006-2009), Biacore International AB (2004-2006), and before that the CEO of Pyrosequencing AB (1998-2004). He has been active in establishing and part of the executive management of companies such as the US based PerSeptive Biosystems Inc., Pharmacia Biosensor AB and Pharmacia Biotech AB.
Mr. Walldén is the Chairman of the Board of Erik Wallden AB and member of the boards of Beactica AB and Symcel AB.
Günter Jagschies
Director
Dr. Günter Jagschies has over 30 years experience from the Bioprocessing area and has held senior management positions in Sales, Marketing, and R&D.
He holds a PhD in Biochemistry from the University of Münster, Germany.
Günter has published numerous papers on the development, manufacturing, and economics of biotherapeutics. In 2012 he received the BioProcess International Award as “Thought Leader of the Decade” in the Downstream Processing category.
He is co-chairing the not-for-profit conference series BioProcessing Asia (BPA), which has run for the first time in Nov 2014. He has been appointed as one of three industry leaders to co-chair the next Recovery of Biologics conference to take place in 2016, the globally leading event in downstream processing science and engineering for biotherapeutics.
Jonathan Royce
Director
Jonathan is a seasoned C-suite leader with over 25 years of leadership experience in the life sciences sector, with a strong track record spanning industrial biotechnology, development, production, and commercial strategy.
He has lead teams at organizations such as Millipore, GE Healthcare, Vironova, and Bio-Works Technologies, where he consistently drove innovation and growth across complex technical and commercial landscapes.
Jonathan holds a Master’s degree in Chemical Engineering from Northeastern University and is widely respected for his ability to align business vision with scientific advancement.
Kristofer Eriksson
Deputy
Kristofer has a PhD in organic chemistry from Stockholm University and is co-inventor of MAGic core technology. Has developed the manufacturing process of the magnetic beads and magnetic separators as well as the downstream applications.